Kexing Biopharm's innovative drug "GB19 Injection" received approval from NMPA to conduct clinical trials in China
Recently, Kexing Biopharm's innovative drug "GB19 Injection" for the treatment of systemic lupus erythematosus (SLE) received approval from National Medical Products Administration (NMPA) to conduct...